NCI Community Cancer Center Program
Bringing Advanced Cancer CareNCCCP
to Underserved Communities

St. Luke’s MSTI was selected in 2010 as a National Cancer Institute (NCI) Community Cancer Center, one of 30 in a national network of centers with a shared mission to expand research and care opportunities at hospitals serving largely rural, suburban, small town, and underserved populations.

PhotoAs a member of the NCI Community Cancer Center Program (NCCCP),
St. Luke’s MSTI is working to:

• Reduce cancer care disparities by improving and expanding services for underserved patients, increasing community outreach activities, and adding more patient navigation services.

• Increase patient access to and participation in clinical trials through better patient education and cultural awareness, and consistent communication with referring physicians.

• Improve the quality of cancer care, screening, and prevention by sharing best practices with other NCI and NCCCP cancer centers and meeting and exceeding the American Society of Clinical
Oncology (ASCO) Quality Oncology Practice Initiative (QOPI®) measures.

• Enhance cancer survivorship and supportive care services with expanded programs.

• Strengthen patient advocacy efforts by building on relationships with community and national partners, and engaging with local and state legislators.

• Connect to cancer research data networks and expand the use of electronic medical records.

• Promote the collection of high quality bio-specimens for research, such as blood and tissue samples, by creating a biorepository.

Our Target Populations
While St. Luke’s MSTI is working to increase access to high quality care for everyone, we place special emphasis on underserved populations. We have identified the underserved populations in our region as people living in rural and “frontier” areas, minorities—particularly people of Hispanic ethnicity—the elderly, adolescents, and young adults.

For more information on the NCCCP, visit ncccp.cancer.gov.


top
  • Cancer Care - Mountain States Tumor Institute
navigation